Compounds > testosterone 4-n-butylcyclohexylcarboxylate
Page last updated: 2024-09-02

testosterone 4-n-butylcyclohexylcarboxylate and Cancer of Prostate

testosterone 4-n-butylcyclohexylcarboxylate has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Attia, DM; Ederveen, AG1

Other Studies

1 other study(ies) available for testosterone 4-n-butylcyclohexylcarboxylate and Cancer of Prostate

ArticleYear
Opposing roles of ERα and ERβ in the genesis and progression of adenocarcinoma in the rat ventral prostate.
    The Prostate, 2012, Jun-15, Volume: 72, Issue:9

    Topics: Adenocarcinoma; Animals; Disease Progression; Estrogen Receptor alpha; Estrogen Receptor beta; Male; Prostate; Prostatic Neoplasms; Rats; Rats, Wistar; Severity of Illness Index; Testosterone

2012